Chronic low-dose infusions of dexamethasone in rats: Effects on blood pressure, body weight and plasma atrial natriuretic peptide

Journal of Hypertension

Volumn 6, Issue 1, 1988, Pages 25-31

  Tonolo, Giancarlo ^a   Fraser, Robert ^a   Connell, John M C ^a   Kenyon, Christopher J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Dietary; Glucocorticoid induced hypertension; Rat

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DEXAMETHASONE;

ANIMAL EXPERIMENT; BLOOD PRESSURE; ETIOLOGY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT; SODIUM INTAKE;

ANIMAL; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; CORTICOSTERONE; DEXAMETHASONE; HYPERTENSION; MALE; POTASSIUM; RATS; RATS, INBRED STRAINS; SODIUM; SODIUM, DIETARY;

EID: 0023872292     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Krakoff LR, Selvadurai R, Sutter E: Effect of methylprednisolone upon arterial pressure and the renin-angiotensin system in the rat. Am J Physiol 1975, 228:613–617.
2. Haack D, Möhring J, Möhring B, Petri M, Hackenthal E: Comparative study on development of corticosterone and DOCA hypertension In rats. Am J Physiol 1977, 233:F403–F411.
3. Kenyon CJ, Saccoccio NA, Morris DJ: Glucocorticoid Inhibition of mineralocorticoid action in the rat. Clin Sci 1984, 67:329–335.
4. Swingle WW, Swingle AJ: Effect of adrenal steroids upon plasma volume of intact and adrenalectomised dogs. Proc Soc Exp Biol Med 1965, 96:446–452.
5. Kenyon CJ, Saccoccio NA, Morris DJ: Aldosterone effects on water and electrolyte metabolism. J Endocrinol 1984, 100:93–100.
6. Handa M, Kondo K, Suzuki H, Saruta T: Dexamethasone hypertension In rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 1984, 6:236–241.
7. Ramos-Frendo B, Eloy L, Grünfeld J-P: Methylprednisolone- induced hypertension in the rat. Evidence against the role of plasma volume changes, vasopressin and renal prostaglandin E2. J Hypertension 1985, 3:461–467.
8. Ashmore J, Morgan D: Metabolic effects of adrenal glucocorticoid hormones. In The Adrenal Cortex edited by Eisenstein AB. London: Churchill, 1967, pp 249–267.
9. Konagaya M, Bernard PA, Max SR: Blockade of glucocorticoid receptor binding and Inhibition of dexamethasone-induced muscle atrophy in the rat by RU 38486, a potent glucocorticoid antagonist. Endocrinology 1986, 119:375–380.
10. Grünfeld J-P, Eloy L, Moura A-M, Ganeval D, Ramos-Frendo B, Worcel M: Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. Hypertension 1985, 7:292–299.
11. Bia MJ, Tyler K, de Fronzo RA: The effect of dexamethasone on renal electrolyte excretion In the rat. Endocrinology 1982, 111:882–888.
12. Hall CE, Hall O: Interaction between deoxycorticosterone treatment, fluid Intake, sodium consumption, blood pressure and organ changes in rats drinking water, saline or sucrose solution. Can J Physiol Pharmacol 1969, 47:81–86.
13. Kenyon CJ, Clark SA, Hannah JAM, Holloway CD, Ingram MC, Llndop G, Towrle A, Ball SG: The relative importance of glucocorticoids and mineralocorticolds in the development of adrenal regeneration hypertension in rats. Acta Endocrinol 1986, 112:389–395.
14. McAreavey D, Brown WB, Murray GD, Robertson JIS: Exchangeable sodium In DOC-salt and post-DOC-salt hypertension In rats. J Hypertension 1985, 3:275–279.
15. Richards AM, Tonolo G, McIntyre GD, Leckie BJ, Robertson JIS: Radio-immunoassay for plasma alpha atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertension 1987, 5:227–236.
16. Fraser R, Guest S, Holmes E, Mason PA, Young J: Comparison of radioimmunoassay and physiochemical methods as means of estimating plasma aldosterone and 11-deoxycorticosterone concentrations. In Steroid Immunoassay edited by Cameron EHD, Hillier SG, Griffiths K, Cardiff: Alpha Omega 1975, pp 283–292.
17. Millar J, Leckle BJ, Morton JJ, Tree M: A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta 1978, 101:5–15.
18. Newman D: The distribution of range in samples from a normal population expressed in terms of an independent estimate of standard deviation. Blometrika 1939, 31:20–30.
19. Siegel S: Correlation and tests of significance. In Non- Parametric Statistics for the Behavioural Sciences edited by Siegel S. Kogakusha: Tokyo-McGraw-HIII, 1956, pp 202–213.
20. Sinha SK, Rodriguiz MJ, Hogan WC, Klahr S: Mechanisms of activation of renal (Na+ + K+)-ATPase In the rat. Effects of acute and chronic administration of dexamethasone. Biochim Biophys Acta 1981, 641:20–35.
21. Fuller PJ, Funder JW: Mineralocorticoid and glucocorticoid receptors in human kidney. Kidney Int 1976, 10:154–157.
22. Lan NC, Graham B, Bartter FC, Baxter JD: Binding of steroids to mineralocorticoid receptors: implications for in vivo occu: pancy by glucocorticoids. J Clin Endocrinol Metab 1982, 54:332–342.
23. Funder JW, Feldman D, Edelman IS: Glucocorticoid receptors in rat kidney: the binding of tritiated dexamethasone. Endocrinology 1973, 92:1005–1013.
24. Grekln RJ, Ling WD, Shenker Y, Bohr DF: Immunoreactive atrial natriuretic hormone levels increase in deoxycorticosterone acetate-treated pigs. Hypertension 1986, 8 (suppl II):II16–1120.
25. Connell JMC, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R: Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertension 1987, 5:425–433.
26. Richards AM, Cleland JGF, Tonolo G, McIntyre GD, Leckie BJ, Dargie HJ, Ball SG, Robertson JIS: Plasma atrial natriuretic peptide in cardiac impairment. Br Med J 1986, 293:409–412.
27. Shenker Y, Sider RS, Ostafin EA, Grekln RJ: Plasma levels of Immunoreactive atrial natriuretic factor in healthy subjects and In patients with edema. J Clin Invest 1985, 76:1684–1687.
28. Luft FC, Sterzel RB, Lang RE, Traboid EM, Veelken R, Ruskoaho H, Gao Y, Ganten D, Unger T: Atrial natriuretic factor determinations and chronic sodium homeostasis. Kidney Int 1986, 29:1004–1010.
29. Weidmann P, Hellmueller B, Uehlinger DE, Lang RE, Gnaedinger MP, Hasler L, Shaw S, Bachmann C: Plasma levels and cardiovascular, endocrine and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab 1986, 62:1027–1036.
30. Suzuki H, Handa M, Kondo K, Saruta T: Role of renin-angio- tensin system in glucocorticoid hypertension In rats. Am J Physiol 1982, 243:E48–E51.
31. Whitworth JA, Saines D, Scoggins BA: Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man. Clin Exp Hypertens, [A] 1984, 6:795–809.
32. Doe RP, Vennes JA, Fink EB: Diurnal variation of 17-hydroxy corticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing’s syndrome. J Clin Endocrinol Metab 1960, 20:253–265.
33. Tourniaire J, Ghalendar D, Rebattu B, Fevre-Montange M, Bajard L, Mazenod B, Dechaud H, Abou Samra AB, Van Cauter E: The 24-h cortisol secretory pattern In Cushing’s syndrome. Acta Endocrinol 1986, 112:230–237.
34. Brown JJ, Davies DL, Lever AF, Robertson JIS: Plasma renin concentration in human hypertension II. Renin in relation to aetiology. Br Med J 1965, 2:1215–1219.
35. Krakoff L, Nicolis G, Amsel B: Pathogenesis of hypertension in Cushing’s syndrome. Am J Med 1975, 58:216–220.